Loading...
Pembrolizumab Utilization and Outcomes for Advanced Melanoma in US Community Oncology Practices
The programmed death-1 inhibitor pembrolizumab has demonstrated efficacy and safety in clinical trials for treating advanced (unresectable/metastatic) melanoma. We investigated the real-world utilization of pembrolizumab and associated patient outcomes for advanced melanoma in US community oncology...
Saved in:
Published in: | J Immunother |
---|---|
Main Authors: | , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Lippincott Williams & Wilkins
2018
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5811239/ https://ncbi.nlm.nih.gov/pubmed/29252916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000204 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|